转自：药明康德彩娱乐注册CLY588.VIP
▎药明康德
上海，2024年12月30日 - 药明康德近日告示公司入选2024年谈琼斯可握续发展寰宇指数（DJSI World）和新兴阛阓指数（DJSI Emerging Markets），这亦然药明康德第四年入选谈琼斯可握续发展指数（DJSI），充分彰显了公司对鼓吹可握续发展和践行负牵累交易推行的矍铄答允。
DJSI是寰球公认的可握续发展参考行为，通过评估企业长期的经济、环境和社会效益，揣测企业的可握续发展发扬。对于将可握续发展纳入轮廓考量的投资者而言，该指数亦然一项进军的参考依据。其中，谈琼斯可握续发展寰宇指数代表了标普寰球BMI指数中最大的2500家公司中名次前10%的公司，而新兴阛阓指数考取了20个新兴阛阓中800 家最大公司的前10%的公司。
入选DJSI的关键成分是企业在标普寰球企业可握续发展评估（S&P Global Corporate Sustainability Assessment, CSA）中的评分。2024年11月，药明康德在2024年CSA评估中取得行业最高分，位列寰球“生命科学用具与办事”界限第一。稀奇值得一提的是，药明康德是该行业界限里入选寰宇指数的四家公司之一，同期亦然惟逐个家入选新兴阛阓指数的公司。
“很庆幸药明康德因在可握续发展和赋能篡改方面的凸起发扬，取得谈琼斯可握续发展指数的招供，并再次同期入选谈琼斯可握续发展寰宇指数和新兴阛阓指数。”药明康德副董事长兼ESG委员会主席胡正国先生默示，“咱们将不时坚握可握续发展计谋，履行企业社会牵累，助力互助伙伴加快新药和冲破性疗法的问世，造福寰球病患。”
当作篡改的赋能者、客户信托的互助伙伴以及寰球健康产业的孝顺者，药明康德将ESG理念融入公司计谋和运营的方方面面。2024年，药明康德在CSA中取得行业最高分，位列寰球“生命科学用具与办事”界限第一；同庚，彩娱乐官网药明康德领悟第四年被MSCI评为ESG AA级，在EcoVadis企业社会牵累评级中取得“金牌”认证；2023和2024年，公司领悟两年入选标普寰球可握续发展年鉴和富时罗素社会牵累指数系列彩娱乐注册CLY588.VIP，并同期获评Sustainalytics“行业最高评级”和“区域最高评级”企业；2024年，公司加入了“联贯国寰球公约组织”（United Nations Global Compact，UNGC），答允援手寰球公约十项原则；2023年，公司加入“科学碳方针倡议”（Science Based Targets initiative，SBTi）以减少碳排放。药明康德出色的ESG发扬也受到了CDP、ISS等寰球ESG评级机构的高度招供。
对于药明康德
药明康德（股票代码：603259.SH/2359.HK）为寰球医药及生命科学行业提供一体化、端到端的新药研发和出产办事，在亚洲、欧洲、北好意思等地均设有运营基地。药明康德通过独有的“CRDMO”和“CTDMO”业务模式，不休缩小研发门槛，助力客户普及研发后果，为患者带来更多冲破性的治愈决策，办事范围涵盖化学药研发和出产、生物学商榷、临床前测试和临床训练研发、精确医疗研发、测试和出产等界限。2024年，药明康德领悟第四年被MSCI评为ESG（环境、社会及管治）AA级。当今，公司的赋能平台正承载着来自寰球30多个国度的6,000多家互助伙伴的研发篡改步地，勤奋于将更多新药、好药带给寰球病患，早日达成“让寰宇莫得难作念的药，难治的病”的愿景。
WuXi AppTec’s Commitment to Sustainability Recognized by the Dow Jones Sustainability Indices (DJSI) for the Fourth Consecutive Year
SHANGHAI, December 30, 2024 - WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science industries, announced that it has been recognized by the prestigious Dow Jones Sustainability Indices (DJSI) for the fourth consecutive year. The company was included in both the 2024 DJSI World and the 2024 DJSI Emerging Markets, an achievement that acknowledges WuXi AppTec’s ongoing commitment to sustainability and the integration of responsible practices across its operations and strategies.
The DJSI is a globally respected benchmark that assesses the sustainability performance of companies based on long-term economic, environmental and social criteria. It is widely used by investors who integrate sustainability considerations into their portfolios. The DJSI World represents the top 10% of the largest 2,500 companies in the S&P Global BMI, while the DJSI Emerging Markets honors the top 10% of the largest 800 companies in 20 emerging markets.
Inclusion in the DJSI is based on a company’s performance in the annual S&P Global Corporate Sustainability Assessment (CSA). In November 2024, WuXi AppTec ranked first in the Life Sciences Tools & Services sector in the 2024 S&P Global CSA. In addition, WuXi AppTec is one of only four companies in its sector globally included in this year’s DJSI World and the only one company included in the DJSI Emerging Markets.
“We are honored that WuXi AppTec has been recognized by DJSI for its commitment to advancing sustainability and has once again been included in both the DJSI World and the DJSI Emerging Markets,” said Edward Hu, Vice Chairman of WuXi AppTec and Chairman of WuXi AppTec’s ESG Committee. “We will continue to emphasize our ESG commitment while supporting our customers to develop and deliver innovative new therapies to patients worldwide.”
As an enabler of innovation, a trusted partner, and a contributor to the global pharmaceutical and life sciences industry, WuXi AppTec integrates ESG priorities in all aspects of its global business operations. In 2024, WuXi AppTec ranked #1 in the Global Life Sciences Tools & Services Industry in S&P Global’s Corporate Sustainability Assessment, received an AA ESG rating from MSCI for the fourth consecutive year, and earned a gold medal in EcoVadis sustainability rating. The company was also named to the S&P Global Sustainability Yearbook and the FTSE4Good Index Series in both 2023 and 2024, and was recognized as an Industry and Regional “Top-Rated” company by Sustainalytics. WuXi AppTec’s outstanding ESG performance has been widely acknowledged by major global ESG rating agencies, including CDP and ISS.
In addition, WuXi AppTec participates in global efforts to advance sustainability. In 2024, WuXi AppTec joined the United Nations Global Compact (UNGC) to support its ten sustainability principles. In 2023, WuXi AppTec joined the Science Based Targets initiative (SBTi) to reduce carbon emissions.
About WuXi AppTec
As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development, and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, advanced therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024, and its open-access platform is enabling more than 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated."
后来了解之后才知道许多姐妹觉得画眉毛太浪费时间，而且自己画出的效果并不好看，画出完美的眉毛比较考验技术，大多数姐妹就去选择简单省事的纹眉。
（转自：药明康德）彩娱乐注册CLY588.VIP